financetom
Business
financetom
/
Business
/
Impinj Insider Sold Shares Worth $1,471,303, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Impinj Insider Sold Shares Worth $1,471,303, According to a Recent SEC Filing
Jun 12, 2024 1:01 AM

03:31 AM EDT, 06/12/2024 (MT Newswires) -- Chris Diorio, Director, Chief Executive Officer, on June 10, 2024, sold 10,000 shares in Impinj ( PI ) for $1,471,303. Following the Form 4 filing with the SEC, Diorio has control over a total of 838,724 shares of the company, with 286,230 shares held directly and 552,494 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1114995/000141588924016431/xslF345X03/form4-06112024_100636.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial
Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial
May 26, 2025
04:10 AM EDT, 05/05/2025 (MT Newswires) -- Recursion Pharmaceuticals ( RXRX ) said Sunday early results from a phase 1/2 trial of its drug REC-4881 for Familial Adenomatous Polyposis showed a median reduction in polyp burden of 43% after 13 weeks among six patients who were evaluated. The company said five patients saw polyp reductions between 31% and 82%, while...
Nanobiotix Says Potential Pancreatic Cancer Treatment Extends Survival in Phase 1 Study
Nanobiotix Says Potential Pancreatic Cancer Treatment Extends Survival in Phase 1 Study
May 26, 2025
04:09 AM EDT, 05/05/2025 (MT Newswires) -- Nanobiotix ( NBTX ) said Monday its JNJ-1900 drug candidate showed a median overall survival of 23 months for certain patients with pancreatic cancer in a phase 1 study. A historical review of 144 patients with locally advanced pancreatic cancer treated at the same center showed a median overall survival of 19.2 months,...
Netflix Insider Sold Shares Worth $2,945,315, According to a Recent SEC Filing
Netflix Insider Sold Shares Worth $2,945,315, According to a Recent SEC Filing
May 26, 2025
04:13 AM EDT, 05/05/2025 (MT Newswires) -- Spencer Adam Neumann, Chief Financial Officer, on May 01, 2025, sold 2,601 shares in Netflix ( NFLX ) for $2,945,315. Following the Form 4 filing with the SEC, Neumann has control over a total of 3,691 common shares of the company, with 3,691 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1065280/000106528025000229/xslF345X05/wk-form4_1746232096.xml ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved